Operating Lease, Right-of-Use Asset in USD of Barinthus Biotherapeutics plc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Barinthus Biotherapeutics plc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2020 to Q3 2025.
  • Barinthus Biotherapeutics plc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2.06M, a 72.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Barinthus Biotherapeutics plc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.06M -$5.38M -72.3% 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $3.32M -$3.96M -54.4% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $3.86M -$3.55M -48% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $4.38M -$3.2M -42.2% 31 Dec 2024 10-Q 07 Nov 2025
Q3 2024 $7.44M -$30K -0.4% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $7.29M -$421K -5.46% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $7.41M -$315K -4.08% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $7.58M -$172K -2.22% 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 $7.47M -$84K -1.11% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $7.71M -$632K -7.58% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $7.72M +$1.02M +15.3% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $7.75M +$496K +6.84% 31 Dec 2022 10-K 20 Mar 2024
Q3 2022 $7.56M -$1.22M -13.9% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $8.34M +$6.3M +309% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $6.7M +$4.6M +219% 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $7.26M +$5.12M +240% 31 Dec 2021 10-K 24 Mar 2023
Q3 2021 $8.78M 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $2.04M 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $2.1M 31 Mar 2021 10-Q 14 Jun 2021
Q4 2020 $2.14M 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.